Articles by Audrey Burton-Bethke

• 

  News
  Unlocking Bispecific Antibody Therapy: A Comprehensive Guide for the Myeloma Community
  Oct 02, 2024
• 

  News
  Why Does Early Intervention in Myelofibrosis Matter?
  Sep 16, 2024
• 

  News
  What Is the Prognosis of a Multiple Myeloma Patient?
  Sep 11, 2024
• 

  News
  HealthTree Foundation Featured on Fox News
  Sep 09, 2024
• 

  News
  Join Us for the Dallas Myeloma Roundtable
  Sep 06, 2024
• 

  News
  Share HealthTree Cure Hub to Accelerate MDS Research
  Aug 28, 2024
• 

  News
  A Story of Faith, Strength, and Courage: Greg Proctor's Journey with Multiple Myeloma
  Aug 23, 2024
• 

  News
  The Power of Exercise for Patients with Myelofibrosis
  Aug 20, 2024
• 

  News
  Testing a New Combination Therapy for Myelofibrosis Treatment
  Aug 12, 2024
• 

  News
  Medicare Prescription Drug Cost Changes for 2024 and 2025
  Aug 09, 2024
• 

  News
  Can't Join a Clinical Trial? Contribute to MDS Research with Real-World Data
  Aug 07, 2024
• 

  News
  Participate in MDS Research: Demographics Survey
  Aug 06, 2024
• 

  News
  Join Us for the October New York Myeloma Roundtable
  Jul 29, 2024
• 

  News
  What is Real-World Data?
  Jul 23, 2024
• 

  News
  ¿Cuáles Son los Síntomas del Mieloma Múltiple?
  Jul 23, 2024
• 

  News
  Is Age Just A Number? Analyzing CAR T-cell Therapy for B-cell Lymphoma
  Jul 22, 2024
• 

  News
  What Is The Prognosis Of A Myelofibrosis Patient?
  Jul 22, 2024
• 

  News
  Predicta Biosciences Raises $5.2M to Improve Myeloma Testing and Monitoring
  Jul 18, 2024
• 

  News
  Real-World CAR T Data for Extramedullary Patients
  Jul 17, 2024
• 

  News
  How Do I Tell My Loved Ones I Have Myelofibrosis?
  Jul 17, 2024
• 

  News
  HealthTree Foundation Featured on ABC News
  Jul 16, 2024
• 

  News
  Track Your MDS Labs with HealthTree Cure Hub
  Jul 16, 2024
• 

  News
  ¿Por Qué Es Necesaria un PET En el Mieloma?
  Jul 15, 2024
• 

  News
  New FDA-Designated Cell Therapy for AML, ALL, and MDS
  Jul 15, 2024